Ordin nr. 1301/500/2008 din 11 iulie 2008 Partea a ii-a

Se aplică tuturor denumirilor comerciale, formelor farmaceutice şi concentraţiilor corespunzătoare DCI-ului.
________________________________________________________________________________

DCI/DENUMIRE COMERCIALĂ FORMA FARM.

__________________________________________________

CONCENTRAŢIE FIRMA

________________________________________________________________________________

L02AE02 LEUPRORELINUM LIOF. + SOLV. PT. SUSP. 11.25 mg

INJ. ELIB. PREL

LUCRIN DEPOT 11.25 mg 11.25 mg ABBOTT LABORATORIES S.A.

L02AE02 LEUPRORELINUM LIOF. + SOLV. PT. SUSP. 11.25 mg

INJ. ELIB. PREL.

ELIGARD 22.5 mg 22.5 mg ASTELLAS PHARMA EUROPE

B.V.
L02AE02 LEUPRORELINUM LIOF. + SOLV. PT. SUSP. 11.25 mg

INJ. ELIB. PREL.

ELIGARD 22.5 mg 22.5 mg ASTELLAS PHARMA EUROPE

B.V.
L02AE02 LEUPRORELINUM LIOF. + SOLV. PT. SUSP. 11.25 mg

INJ. ELIB. PREL.

ELIGARD 7.5 mg 7.5 mg ASTELLAS PHARMA EUROPE

B.V.
L02AE02 LEUPRORELINUM LIOF. + SOLV. PT. SUSP.

INJ. ELIB. PREL.

LUCRIN DEPOT 3,75 mg 3.75 mg ABBOTT LABORATORIES

________________________________________________________________________________
______________________________________________________________________________

| 762 |L02AE03| GOSERELINUM** | |

|_______|_______|____________________________________________|_________________|
________________________________________________________________________________

DCI/DENUMIRE COMERCIALĂ FORMA FARM.

__________________________________________________

CONCENTRAŢIE FIRMA

________________________________________________________________________________

L02AE03 GOSERELINUM IMPLANT 3.6 mg

ZOLADEX(R) 3.6 mg ASTRAZENECA UK LTD.
Prescriere limitată: Cancer de prostată hormonodependent avansat local (echivalent stadiului T3 - T4) sau metastatic (echivalent stadiului M1).

Prescriere limitată: Cancer de sân hormonodependent avansat local (echivalent cu stadiul III) sau metastatic (echivalent cu stadiul IV) la femei în premenopauză.

________________________________________________________________________________
______________________________________________________________________________

| 763 |L02AE04| TRIPTORELINUM** | |

|_______|_______|____________________________________________|_________________|
Prescriere limitată: Cancer de prostata hormonodependent avansat local (echivalent stadiului T3 - T4) sau metastatic (echivalent stadiului M1).